← Oncology Approval Tracker

FDA DECISION ·

Axtle

pemetrexed · Avyxa Holdings

FDA approvalNew or expanded indicationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With pembrolizumab and platinum chemotherapy for initial treatment of metastatic nonsquamous NSCLC without EGFR or ALK genomic tumor aberrations.

LAMPGEN ANALYSIS

Why it matters

This approval adds the first-line chemoimmunotherapy use to the Axtle pemetrexed label.

What research teams should watch

Verify histology and driver testing and build folate and vitamin B12 supplementation into treatment preparation.

PRIMARY RECORDS

Sources